Seqera Labs, a leading provider of secure workflow orchestration software in the life sciences sector, has partnered with Genomics England. The new collaboration between Seqera Labs and Genomics England will enable whole genome analysis to be carried out at a larger scale with greater efficiency, helping more patients benefit from genomic healthcare and equipping researchers with extra data to find the causes of disease and develop new treatments.
Building on the UK’s reputation as a global leader in life sciences, Genomics England is working with the NHS to deliver whole genome sequencing as part of the NHS Genomic Medicine Service for patients with rare diseases and cancer. The data collected by Genomics England is stored in the National Genomic Research Library and can be accessed by approved researchers via a secure research environment enabling them to deliver ground-breaking insights into both therapeutics and diagnostics, and has been used by scientists to propose updated global guidelines to improve rare disease diagnosis.
The partnership with Seqera Labs will scale Genomics England’s capacity to develop models for disease diagnosis, prognosis and treatment response. Genomics England will deploy Seqera Labs’ Nextflow Tower – an intuitive, centralised command post that enables large-scale collaborative data analysis. With Tower, Genomics England will be able to quickly launch, manage and monitor scalable data analysis pipelines within the cloud.
Click below to share this article